For years, people fighting addiction have had few options that work well. Many treatments leave patients still dealing with cravings and high relapse rates. But new research points to a promising option: psilocybin, the active compound in "magic mushrooms. "Recent studies show that psilocybin therapy...
The renaissance of psychedelic research has brought new hope for treating conditions like depression, PTSD, and addiction. But as these once-stigmatized substances move from underground use to mainstream medicine, researchers face unique challenges in designing, conducting, and reporting their studies. The quality of this reporting...
Depression affects millions of people worldwide, and finding effective treatments remains a challenge for many. While traditional antidepressants like selective serotonin reuptake inhibitors (SSRIs) have been the standard approach for decades, psychedelic therapy has emerged as a promising alternative. Two treatments in particular—the SSRI escitalopram...
For years, people with bipolar disorder have been systematically excluded from clinical trials of psychedelic therapy. Despite promising results for psychedelics in treating depression, anxiety, and other mental health conditions, researchers have been hesitant to include bipolar patients due to concerns about triggering manic episodes....